Andrée Delahaye-Duriez (Andree Delahaye-Duriez)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 8

Top Venues

Nutrients

Genome biology

European journal of human genetics : EJHG

Medecine sciences : M/S

INSERM

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Jan 01 2019

France

Group leader :: Neurodiderot

Université Paris 13 UFR de Santé Médecine Biologie Humaine

France

PU-PH

Imperial College London Sep 01 2016 - Sep 01 2019

United Kingdom

Honorary Clinical lecturer :: Brain Sciences Department, Faculty of Medicine

Université Sorbonne Paris Cité

France

MCU-PH :: UFR SMBH, Université Paris 13

Imperial College London Sep 01 2014 - Sep 01 2016

United Kingdom

Marie-Curie Fellow :: Institut of Clinical Sciences

Publications

Laila El Khattabi, Fabien Guimiot, Andrée Delahaye-Duriez
Reply to Pubpeer anonymous contributors: incomplete penetrance and phenotypic variability of 6q16 deletions including SIM1. European journal of human genetics : EJHG 30 (9) (2022)
Shi-Xiao Peng, Jingwen Pei, Berardo Rinaldi, Jiang Chen, Yu-Han Ge, Min Jia, Jun Wang, Andrée Delahaye-Duriez, Jia-Hui Sun, Yan-Yu Zang, Yong-Yun Shi, Ning Zhang, Xiang Gao, Donatella Milani, Xijia Xu, Nengyin Sheng, Benedicte Gerard, Chen Zhang, Carolina Alvarez, Na Liu, Jian-Jun Yang, Yun Stone Shi
Dysfunction of AMPA receptor GluA3 is associated with aggressive behavior in human. Molecular psychiatry 27 (10) (2022)
Manuela Zinni, Julien Pansiot, Marina Colella, Valerie Faivre, Andrée Delahaye-Duriez, François Guillonneau, Johanna Bruce, Virginie Salnot, Jérôme Mairesse, Marit Knoop, Marie-Laure Possovre, Daniel Vaiman, Olivier Baud
Impact of Fetal Growth Restriction on the Neonatal Microglial Proteome in the Rat. Nutrients 13 (11) (2021)
Lise Larcher, Julien Buratti, Bénédicte Héron-Longe, Brigitte Benzacken, Eva Pipiras, Boris Keren, Andrée Delahaye-Duriez
New evidence that biallelic loss of function in EEF1B2 gene leads to intellectual disability. Clinical genetics 97 (4) (2020)
Andrée Delahaye-Duriez, Clémence Réda, Pierre Gressens
[Identification of therapeutic targets and drug repurposing via gene network analysis]. Medecine sciences : M/S 35 (6-7) (2019)
Liisi Laaniste, Prashant K Srivastava, Julianna Stylianou, Nelofer Syed, Silvia Cases-Cunillera, Kirill Shkura, Qingyu Zeng, Owen J L Rackham, Sarah R Langley, Andrée Delahaye-Duriez, Kevin O'Neill, Matthew Williams, Albert Becker, Federico Roncaroli, Enrico Petretto, Michael R Johnson
Integrated systems-genetic analyses reveal a network target for delaying glioma progression. Annals of clinical and translational neurology 6 (9) (2019)
Prashant K Srivastava, Jonathan van Eyll, Patrice Godard, Manuela Mazzuferi, Andrée Delahaye-Duriez, Juliette Van Steenwinckel, Pierre Gressens, Benedicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet-Coello, Alvaro Cardenas, Frederic Vanclef, Liisi Laaniste, Isabelle Niespodziany, James Keaney, Julien Gasser, Gaelle Gillet, Kirill Shkura, Seon-Ah Chong, Jacques Behmoaras, Irena Kadiu, Enrico Petretto, Rafal M Kaminski, Michael R Johnson
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target. Nature communications 9 (1) (2018)
Andrée Delahaye-Duriez, Prashant Srivastava, Kirill Shkura, Sarah R Langley, Liisi Laaniste, Aida Moreno-Moral, Bénédicte Danis, Manuela Mazzuferi, Patrik Foerch, Elena V Gazina, Kay Richards, Steven Petrou, Rafal M Kaminski, Enrico Petretto, Michael R Johnson
Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery. Genome biology 17 (1) (2016)

Andrée Delahaye-Duriez.css-eqlu8i{font-size:small;padding-left:4px;} (Andree Delahaye-Duriez)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrée Delahaye-Duriez (Andree Delahaye-Duriez)